Table 2 Eighteen subsequent malignancies occurred in PPBL patients
From: Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification
Patients | Delay between PPBL and subsequent malignancy’s diagnosis | Type of malignancy | Follow-up |
|---|---|---|---|
UPN36 | 38 months | DLBCL | 56 months |
UPN47 | 20 months | SMZL | +65 months |
UPN57 | 92 months | DLBCL | 99 months |
UPN63 | Diagnosis of PPBL and lymphoma was concomitant | DLBCL | +13 months |
UPN71 | 77 months | SMZL | +86 months |
UPN83 | 120 months | DLBCL | +131 months |
UPN1 | 264 months | MGUS | +348 months |
UPN10 | 144 months | MGUS | +148 months |
UPN157 | 44 months | MGUS | +47 months |
UPN118 | Diagnosis of PPBL and MGUS was concomitant | MGUS | +36 months |
UPN163 | Diagnosis of PPBL and MGUS was concomitant | MGUS | +57 months |
UPN105 | Diagnosis of PPBL and MGUS was concomitant | MGUS | +42 months |
UPN5 | 96 months | Mammary carcinoma | +272 months |
UPN6 | 3 months | Pulmonary carcinoma | 3 months |
UPN70 | 22 months | Pulmonary carcinoma | +22 months |
UPN86 | 132 months | Pulmonary carcinoma | +146 months |
UPN160 | 114 months | Pulmonary carcinoma | 112 months |
UPN67 | 156 months | Cervical carcinoma | +181 months |